Peripheral T-cell lymphoma
Active Research Protocols
- 01-C-0049 – Phase II Trial of Depsipeptide in Patients with Cutaneous T-Cell Lymphoma and Relapsed Peripheral T-Cell Lymphoma
- 04-C-0031 – Phase I Trial of Medi-507 in CD2-Positive Lymphoproliferative Disease
- 97-C-0110 – Phase I/II Study of Tac-Expressing Malignancies Other than Adult T-Cell Leukemia (ATL) with Yttrium-90 Radiolabeled Humanized Anti-Tac and Calcium-DTPA
NOTE: PDF documents require the freeAdobe Reader.
This page was last updated: January 24, 2014